| Primary |
| Rhinitis Allergic |
14.8% |
| Hypersensitivity |
9.9% |
| Hypertension |
8.6% |
| Eczema |
7.4% |
| Multiple Allergies |
7.4% |
| Urticaria |
7.4% |
| Product Used For Unknown Indication |
6.2% |
| Angioedema |
4.9% |
| Drug Use For Unknown Indication |
3.7% |
| Gout |
3.7% |
| Hepatitis C |
3.7% |
| Dermatitis |
2.5% |
| Diabetes Mellitus Non-insulin-dependent |
2.5% |
| Dry Skin |
2.5% |
| Infection |
2.5% |
| Insomnia |
2.5% |
| Rash |
2.5% |
| Seasonal Allergy |
2.5% |
| Sinus Congestion |
2.5% |
| Vertigo |
2.5% |
|
| Syncope |
10.7% |
| Ventricular Fibrillation |
10.7% |
| Hypertension |
7.1% |
| Tachycardia |
7.1% |
| Dyspnoea |
5.4% |
| Off Label Use |
5.4% |
| Urticaria |
5.4% |
| Vomiting |
5.4% |
| Agitation |
3.6% |
| Arrhythmia |
3.6% |
| Cardiac Enzymes Increased |
3.6% |
| Drug Ineffective |
3.6% |
| Dystonia |
3.6% |
| Fatigue |
3.6% |
| Haemoptysis |
3.6% |
| Headache |
3.6% |
| Intracranial Pressure Increased |
3.6% |
| Loss Of Consciousness |
3.6% |
| Nausea |
3.6% |
| Overdose |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
21.4% |
| Drug Use For Unknown Indication |
10.2% |
| Grand Mal Convulsion |
6.1% |
| Supraventricular Tachycardia |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.7% |
| Thrombosis Prophylaxis |
4.7% |
| Major Depression |
4.1% |
| Pain |
4.1% |
| Epilepsy |
3.7% |
| Nausea |
3.7% |
| Rhinitis Allergic |
3.7% |
| Asthma |
3.4% |
| Insomnia |
3.4% |
| Nasopharyngitis |
3.4% |
| Suicide Attempt |
3.4% |
| Upper Respiratory Tract Inflammation |
3.4% |
| Dermatitis |
3.1% |
| Essential Hypertension |
2.7% |
| Hypercholesterolaemia |
2.7% |
| Renal Colic |
2.7% |
|
| Off Label Use |
13.0% |
| Completed Suicide |
10.9% |
| Toxic Epidermal Necrolysis |
10.9% |
| Drug Toxicity |
6.5% |
| Respiratory Arrest |
6.5% |
| Stent Placement |
6.5% |
| Abnormal Behaviour |
4.3% |
| Cardiac Failure |
4.3% |
| Cardio-respiratory Arrest |
4.3% |
| Oedema |
4.3% |
| Overdose |
4.3% |
| Rash |
4.3% |
| Stereotypy |
4.3% |
| Agitation |
2.2% |
| Arrhythmia |
2.2% |
| Bradyphrenia |
2.2% |
| Breast Cancer |
2.2% |
| Death |
2.2% |
| Drug Abuse |
2.2% |
| Drug Ineffective |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.1% |
| Pruritus |
7.4% |
| Hypertension |
7.0% |
| Gastroenteritis |
5.5% |
| Nasopharyngitis |
4.8% |
| Rheumatoid Arthritis |
4.3% |
| Upper Respiratory Tract Infection |
4.3% |
| Insomnia |
3.8% |
| Diarrhoea |
3.1% |
| Constipation |
3.0% |
| Asthma |
2.7% |
| Prophylaxis |
2.7% |
| Drug Use For Unknown Indication |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Hypersensitivity |
2.5% |
| Pain |
2.4% |
| Conjunctivitis |
2.4% |
| Depression |
2.2% |
| Diabetes Mellitus |
1.9% |
| Hypercholesterolaemia |
1.7% |
|
| Vomiting |
9.3% |
| Nausea |
7.9% |
| Weight Increased |
7.0% |
| Rash |
6.0% |
| Weight Decreased |
6.0% |
| Headache |
5.6% |
| Pyrexia |
5.6% |
| Urinary Tract Infection |
5.6% |
| Syncope |
5.1% |
| Tremor |
5.1% |
| Pneumonia |
4.7% |
| Glomerulonephritis Minimal Lesion |
4.2% |
| Product Quality Issue |
4.2% |
| Diarrhoea |
3.7% |
| Drug Ineffective |
3.7% |
| Flushing |
3.3% |
| Gastroenteritis |
3.3% |
| Injection Site Pain |
3.3% |
| Injection Site Reaction |
3.3% |
| Nasopharyngitis |
3.3% |
|
| Interacting |
| Attention Deficit/hyperactivity Disorder |
30.8% |
| Laryngitis |
30.8% |
| Sinusitis |
30.8% |
| Hypersensitivity |
7.7% |
|
| Syncope |
80.0% |
| Epistaxis |
20.0% |
|
